Automate Your Wheel Strategy on STSSW
With Tiblio's Option Bot, you can configure your own wheel strategy including STSSW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol STSSW
- Rev/Share 0.0
- Book/Share 202.9582
- PB 0.0176
- Debt/Equity 0.0
- CurrentRatio 1.6132
- ROIC -0.8167
- MktCap 3638105.0
- FreeCF/Share -141.5425
- PFCF -0.5147
- PE -0.0279
- Debt/Assets 0.0
- DivYield 0
- ROE -0.9878
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
No ratings available. |
News
About Sharps Technology, Inc. (STSSW)
- IPO Date 2022-04-14
- Website https://sharpstechnology.com
- Industry Financial - Capital Markets
- CEO Mr. Robert M. Hayes
- Employees 55
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.